Vitamin markets: Vitamin A and E remain static and high priced
Cholin Chlorid from China will also be investigated for potential anti-dumping into Europe. The EU commission has started an official investigation, just like with lysine. Creating similar market dynamics for vitamin A and E. Learn more in this week’s feed additives snapshot (week 45).
Suppliers would like to see the current high prices stick and buyers are contracted for Q4 and want to see if prices will go down in the coming period. So there is a waiting game going on for now. Prices are stable to slightly weaker.
Some suppliers are offering vitamin D3 500 at a small discount now and availability seems to improve a bit in several regions. Vitamin B3 has gone quiet as the product has been well contracted ahead.
Other vitamins show little change compared to previous weeks.
In partnership with Feed Additive Prices
Vitamin E 50%
There is a dynamic going on where suppliers would like to at least maintain current prices or increase them and at the same time buyers are having a strong wait-and-see attitude. Most material has been contracted ahead for Q4 and partially Q1 and the contract execution and availability seem to be okay at the moment. Prices are stable right now at a high level and the coming months will have to bring more indication on the price direction. Right now the market is relatively quiet.
Vitamin A 1000
There is a very specific quiet atmosphere in the market, a market that is clearly looking for direction. Sellers would like to maintain the current price level and indicate that they have limited volume available or do not offer at all. Buyers have a strong wait-and-see attitude as they have enough material for the time being and want to observe first if the current high price levels are going to stick. Prices have softened somewhat but remain at a high level compared to earlier this year. Buyers have already secured most of their Q4 and some Q1 needs.
Vitamin D3 500
After a period of tightness and high prices, some first relief is now reported in terms of pricing and availability. Although marginal still. Most buyers are contracted ahead and new demand is slow. Some traders have been more proactive in moving volume at a slight discount. Q4 is mostly contracted and a small portion of Q1 as well. But in general, the market is in a wait-and-see mode.
Vitamin B2 80%
Prices in Europe remain firmer compared to earlier this year, as there are no Chinese sources available, and Western sources indicate to have limited material available. By now most of Q4 has been contracted.
D-Calpan
There were some short-lived indications that prices may increase a bit, but it did not translate into actual higher transaction prices. It seemed wishful thinking so far. The d-calpan market has been very steady and prices remain at a very low level. As there is an oversupply situation for this product, no signs of nearby change are expected. Q4 is mostly contracted and a small portion of Q1 as well.
Vitamin B3
The vitamin B3 market has gone relatively quiet. After the recent price increase, buyers have secured their Q4 and partially Q1 needs and after that, the market has gone quiet. Contract execution and availability seem to be okay. Suppliers still have a relatively strong desire to increase prices further in the near future.
Biotin
No signs of any sort of change in the biotin market are seen or reported. Very static market at the moment. New additional production capacity in China has recently been announced for 2025. Q4 and a good portion of Q1 are contracted.
Vitamin C 35% mono
After some activity in the past few weeks and some firmer pricing, the market has become quiet again. Suppliers continue to insist on higher prices, therefore the current price level seems to be sticking. Q4 and a portion of Q1 have been contracted.
